A team of researchers are working on an implantable device that would communicate with an external control module and glasses.
A Chicago startup that seeks to 3-D print human hearts for transplantation has added to its scientific advisory board of heavy hitters. But just how close is the company to producing its first viable heart?
FDA cleared Cianna Medical's Savi Scout reflector for breast cancer conservation surgery without restrictions on the length of time the implant can remain in the breast.
The company now has CE mark for its Intellis platform for both Spinal Cord Stimulation and Peripheral Nerve Stimulation as an aid in the management of certain types of chronic pain.
The Gore Excluder AAA Endoprosthesis, used to seal off abdominal aortic aneurysms, launched in Europe 20 years ago. Find out how the product has evolved over the past two decades.
Researchers are pioneering technology that could converge to enable pacemakers to be powered by longer-lasting sustainable energy.
Len Czuba, president of Czuba Enterprises, shares tips about developing implantable devices, and the keys to sourcing the best materials without spending a fortune.
After pausing its trials for its CardiAQ transcatheter mitral valve replacement earlier this year, Edwards Lifesciences announced implants are now being performed. Implants of the CardiAQ transcatheter mitral valve system are underway again. Early this year, transcatheter aortic valve replacement (...
Researchers have shown that the company’s in-development leadless pacemaker successfully delivers anti-tachycardia pacing and works in tandem with the subcutaneous ICD. What’s next for the technology?
Edwards Lifesciences posted U.S. transcatheter aortic valve revenue that impressed industry analysts. Here are the factors that buoyed sales and what management expects for the near future. Numerous factors, including faster growth from new hospitals, drove Edwards Lifesciences' strong first...
Glaukos Corp., known for developing innovative new technologies designed to treat glaucoma, has acquired a new early-stage sensor technology from DOSE Medical, dubbed the intraocular pressure sensor system. Kristopher Sturgis Glaukos Corp. continues to establish itself as a leader in the...
As the latest findings on Abbott’s bioresorbable stent were presented at a major medical meeting, FDA issued an alert regarding the product. Yet there may be a bright side to the clinical results.